These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24651566)

  • 1. Sample size considerations in the design of cluster randomized trials of combination HIV prevention.
    Wang R; Goyal R; Lei Q; Essex M; De Gruttola V
    Clin Trials; 2014 Jun; 11(3):309-318. PubMed ID: 24651566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD; Diaz RM; Flanders WD; Goodman M; Hill AN; Holtgrave D; Malow R; McClellan WM
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001230. PubMed ID: 18646068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial.
    Wirth KE; Gaolathe T; Pretorius Holme M; Mmalane M; Kadima E; Chakalisa U; Manyake K; Matildah Mbikiwa A; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Bennett K; Leidner J; Powis KM; Lebelonyane R; Alwano MG; Jarvis J; Dryden-Peterson SL; Kgathi C; Moore J; Bachanas P; Raizes E; Abrams W; Block L; Sento B; Novitsky V; El-Halabi S; Marukutira T; Mills LA; Sexton C; Pals S; Shapiro RL; Wang R; Lei Q; DeGruttola V; Makhema J; Essex M; Lockman S; Tchetgen Tchetgen EJ
    Lancet HIV; 2020 Jun; 7(6):e422-e433. PubMed ID: 32504575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Inter-ministerial National Structural Intervention trial (INSTRUCT): protocol for a parallel group cluster randomised controlled trial of a structural intervention to reduce HIV infection among young women in Botswana.
    Cockcroft A; Marokoane N; Kgakole L; Kefas J; Andersson N
    BMC Health Serv Res; 2018 Oct; 18(1):822. PubMed ID: 30376834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
    Kennedy-Shaffer L; Hughes MD
    Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stochastic variation in network epidemic models: implications for the design of community level HIV prevention trials.
    Boren D; Sullivan PS; Beyrer C; Baral SD; Bekker LG; Brookmeyer R
    Stat Med; 2014 Sep; 33(22):3894-904. PubMed ID: 24737621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogenetic relatedness of circulating HIV-1C variants in Mochudi, Botswana.
    Novitsky V; Bussmann H; Logan A; Moyo S; van Widenfelt E; Okui L; Mmalane M; Baca J; Buck L; Phillips E; Tim D; McLane MF; Lei Q; Wang R; Makhema J; Lockman S; DeGruttola V; Essex M
    PLoS One; 2013; 8(12):e80589. PubMed ID: 24349005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial.
    Balzer L; Staples P; Onnela JP; DeGruttola V
    Clin Trials; 2017 Apr; 14(2):201-210. PubMed ID: 28124579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.
    Lockman S; Holme MP; Makhema J; Bachanas P; Moore J; Wirth KE; Lebelonyane R; Essex M
    Curr HIV/AIDS Rep; 2020 Oct; 17(5):478-486. PubMed ID: 32797382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging contact network structure in the design of cluster randomized trials.
    Harling G; Wang R; Onnela JP; De Gruttola V
    Clin Trials; 2017 Feb; 14(1):37-47. PubMed ID: 27798376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa.
    Todd J; Carpenter L; Li X; Nakiyingi J; Gray R; Hayes R
    Int J Epidemiol; 2003 Oct; 32(5):755-62. PubMed ID: 14559745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design.
    Hayes R; Mosha F; Nicoll A; Grosskurth H; Newell J; Todd J; Killewo J; Rugemalila J; Mabey D
    AIDS; 1995 Aug; 9(8):919-26. PubMed ID: 7576328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.
    Ussery F; Bachanas P; Alwano MG; Lebelonyane R; Block L; Wirth K; Ussery G; Sento B; Gaolathe T; Kadima E; Abrams W; Segolodi T; Hader S; Lockman S; Moore J
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):9-16. PubMed ID: 35537094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
    Jackson CL; Colborn K; Gao D; Rao S; Slater HC; Parikh S; Foy BD; Kittelson J
    Clin Trials; 2021 Oct; 18(5):582-593. PubMed ID: 34218684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing knowledge of HIV status in a country with high HIV testing coverage: Results from the Botswana Combination Prevention Project.
    Alwano MG; Bachanas P; Block L; Roland M; Sento B; Behel S; Lebelonyane R; Wirth K; Ussery F; Bapati W; Motswere-Chirwa C; Abrams W; Ussery G; Miller JA; Bile E; Fonjungo P; Kgwadu A; Holme MP; Del Castillo L; Gaolathe T; Leme K; Majingo N; Lockman S; Makhema J; Bock N; Moore J
    PLoS One; 2019; 14(11):e0225076. PubMed ID: 31765394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of HIV-1C Transmission Networks Reveals Extensive Spread of Viral Lineages Across Villages in Botswana Treatment-as-Prevention Trial.
    Novitsky V; Zahralban-Steele M; Moyo S; Nkhisang T; Maruapula D; McLane MF; Leidner J; Bennett K; ; Wirth KE; Gaolathe T; Kadima E; Chakalisa U; Pretorius Holme M; Lockman S; Mmalane M; Makhema J; Gaseitsiwe S; DeGruttola V; Essex M
    J Infect Dis; 2020 Nov; 222(10):1670-1680. PubMed ID: 32492145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size and power considerations for cluster randomized trials with count outcomes subject to right truncation.
    Li F; Tong G
    Biom J; 2021 Jun; 63(5):1052-1071. PubMed ID: 33751620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.